Atlanta, GA (PRWEB) January 24, 2012
Aderans Research is attracting attention in the medical community once again; this time, the leader in cellular based hair regeneration made waves at the 2012 Winter Clinical Dermatology Conference in Maui.
Aderans Research Chief Executive Officer Ken Washenik, M.D., Ph.D., gave a presentation entitled “Emerging Therapies for Hair Loss.” He also participated in a conference faculty question and answer session with the audience, primarily comprised of practicing dermatologists.
His lecture centered on new and breakthrough treatments in the field of hair loss, including clinical ways of addressing the issue. Washenik addressed the progress Aderans Research is making with its Ji Gami™ family of cell products—a key part of the company’s cell-based solutions to androgenetic alopecia, or pattern hair loss.
“Our cell engineering process continues to be one of the most promising avenues on the horizon for treatment of androgenetic alopecia,” commented Vern Liebmann, Chief Operating Officer. “Our clinical trial is going strong, and we are working to conclude Phase 2 by next year, which will take us one step closer to finding a cure.”
A pioneer in its field, Aderans Research is committed to developing cutting-edge solutions for those who struggle with hair loss. For more information about Aderans Research, visit http://www.aderansresearch.com.
About Aderans Research
Aderans Research is a pioneer in the research and development of safe, effective cell engineered products for hair regeneration. Located in Atlanta, Aderans Research is a subsidiary of Aderans Co., Ltd, the world’s largest wig manufacturer, and affiliate of Bosley, a global leader in surgical hair restoration.
Ongoing information on ARI’s clinical study can be seen at http://aderansresearch.com/ari_clinicalupdates.html.
Additional information on ARI can be found at http://www.aderansresearch.com.
Learn more about ARI’s parent company Aderans Co., Ltd. at